In last trading session, Solid Biosciences Inc (NASDAQ:SLDB) saw 0.36 million shares changing hands with its beta currently measuring 2.00. Company’s recent per share price level of $3.18 trading at -$0.14 or -4.22% at ring of the bell on the day assigns it a market valuation of $127.06M. That closing price of SLDB’s stock is at a discount of -373.27% from its 52-week high price of $15.05 and is indicating a premium of 8.18% from its 52-week low price of $2.92. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.55 million shares which gives us an average trading volume of 420.91K if we extend that period to 3-months.
For Solid Biosciences Inc (SLDB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.09. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.78 in the current quarter.
Solid Biosciences Inc (NASDAQ:SLDB) trade information
Upright in the red during last session for losing -4.22%, in the last five days SLDB remained trading in the red while hitting it’s week-highest on Thursday, 01/30/25 when the stock touched $3.18 price level, adding 8.36% to its value on the day. Solid Biosciences Inc’s shares saw a change of -20.50% in year-to-date performance and have moved -0.93% in past 5-day. Solid Biosciences Inc (NASDAQ:SLDB) showed a performance of -21.87% in past 30-days. Number of shares sold short was 2.33 million shares which calculate 4.23 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 19 to the stock, which implies a rise of 83.26% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 20. It follows that stock’s current price would drop -277.36% in reaching the projected high whereas dropping to the targeted low would mean a loss of -277.36% for stock’s current value.
Solid Biosciences Inc (SLDB) estimates and forecasts
Statistics highlight that Solid Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -64.35% of value to its shares in past 6 months, showing an annual growth rate of 41.20% while that of industry is 16.00. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 32.21% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 40.08% while estimates for its earnings growth in next 5 years are of 16.75%.
Solid Biosciences Inc (NASDAQ:SLDB)’s Major holders
Insiders are in possession of 0.85% of company’s total shares while institution are holding 90.27 percent of that, with stock having share float percentage of 91.05%. Investors also watch the number of corporate investors in a company very closely, which is 90.27% institutions for Solid Biosciences Inc that are currently holding shares of the company.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 854.68 shares of worth $2.72 million or 2.14% of the total outstanding shares. The later fund manager was in possession of 650.02 shares on Nov 30, 2024 , making its stake of worth around $2.07 million in the company or a holder of 1.63% of company’s stock.
